Private Equity Is Back In 2026: What Renewed Deal Activity Means for Hiring

Categories

After a cautious stretch, private equity investment in medical devices is regaining momentum. Global healthcare PE deals reached nearly $71 billion in 2025, buoyed by interest in durable device segments and recurring revenue models. Deal volume in med device is up more than 12% year-over-year as capital flows back into the space.

Historically, PE involvement triggers rapid organizational change. Within 12–24 months of an acquisition, leadership teams are often refreshed, commercial strategies retooled, and headcount expanded—especially in sales, marketing, and operations.
Growth targets accelerate, and execution becomes critical. Companies seek territory managers who can drive double-digit annual growth, clinical specialists adept at shortening sales cycles, and commercial leaders with experience scaling revenue quickly.

For candidates, PE-backed environments offer opportunity—but also higher accountability. Turnover in PE-owned device businesses is roughly 1.5x the industry average when growth expectations aren’t met.

Why This Matters to Hiring Managers

Hiring delays directly affect valuation and exit timing. Whether building out a sales force post-acquisition or upgrading leadership ahead of an exit, speed and precision in hiring are essential. Partnering with recruiters like Med-Search, who understand PE timelines and compensation structures, can shorten searches by 30–50% and improve retention.